Log in to search using one of your social media accounts:

 

Roche's star MS medicine Ocrevus wins EU approval

ZURICH (Reuters) - The European Union approved Roche's multiple sclerosis medicine Ocrevus, one the Swiss company's key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Multiple sclerosis —MS. These two letters can change lives in an instant for young people starting out in their careers and family life. MS is hard to define, hard to treat, and hard to take. Yet over the past two decades, treatment has changed radically, from none to over a dozen disease modifying drugs that can re duce attack rate and mitigate disability. The 2017 revisions of the multiple sclerosis diagnostic criteria1 provide an opportunity for reflection.
Source: Lancet Neurology - Category: Neurology Authors: Tags: In Context Source Type: research
Publication date: February 2018 Source:The Lancet Neurology, Volume 17, Issue 2 Author(s): Jeremy Chataway
Source: The Lancet Neurology - Category: Neurology Source Type: research
When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. Surrounded by lakes, oceans and mountains, Kerala, India, is the birthplace of Ayurveda medicine. My plane landed in Mumbai. From there, I made the 800-mile trip to Kerala down on the southwestern-most tip of the Indian peninsula. With origins dating back 6,000 years, Kerala is the birthplace of Ayurvedic medicine. I spent a lot of time at the AyurMana or “ancient healing house.” This is the oldest existing school of Ayurvedic medicine in the world. It was there that I observed how quickly...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Health Natural Cures anxiety arthritis Cancer celiac disease chronic fatigue depression diabetes digestive issues fibromyalgia leaky gut multiple sclerosis schizophrenia Source Type: news
Conditions:   Multiple Sclerosis, Relapsing-Remitting;   Optic Neuritis Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT) Sponsor:   Medical University of Vienna Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Multiple Sclerosis;   Neurodegeneration;   Central Nervous System Lesion;   Peripheral Nervous System Problem;   Neurologic Deficits;   Drug Effect;   Genetic Disease;   Neurophysiologic Abnormality Intervention:   Sponsors:   University of Southern Denmark;   Region of Southern Denmark Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Multiple Sclerosis, Relapsing-Remitting;   Optic Neuritis Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT) Sponsor:   Medical University of Vienna Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Multiple Sclerosis;   Neurodegeneration;   Central Nervous System Lesion;   Peripheral Nervous System Problem;   Neurologic Deficits;   Drug Effect;   Genetic Disease;   Neurophysiologic Abnormality Intervention:   Sponsors:   University of Southern Denmark;   Region of Southern Denmark Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Progressive Multifocal Leukoencephalopathy Intervention:   Biological: Tysabri Sponsor:   Biogen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
DISCUSSION: Among cognitively normal older adults MoCA performance remains relatively stable over time, however across the older adult age-span MoCA performance declines in a linear fashion. These results will help clinicians better understand the normal course of MoCA change in older adults while researchers may use these results to inform sample size estimates for intervention studies. Cognitive monitoring and testing in the near future: The FDA clears two computerized cognitive tests to assist in medical evaluations following brain injury or concussion Biopharma embraces digital cognitive assessments to identify ...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Age-associated Alzheimer’s Disease cognition Cognitive variability cognitive-decline cognitive-function cognitive-screening executive brain function Intraindividual change memory impairment Source Type: blogs
Estimates from individual provinces suggest that the prevalence of multiple sclerosis (MS) among Canadians may be one of the highest in the world. A new study released today in the publication Health Reports provides information on the impact MS has on people's lives, such as mobility, pain, sleep and cognition. About two-thirds of those diagnosed reported that their lives were affected moderately, quite a bit, or extremely by MS.
Source: Statistics Canada, The Daily: Health - Category: Statistics Source Type: research
More News: Health | Multiple Sclerosis | Switzerland Health